Dupuytren's disease is a condition where the thick layer of tissue located between the skin and the tendons of the palm is thickened and/or contracted. Sometimes nodules and cords can be felt as ...

Injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules is effective in reducing nodule hardness and nodule size. Researchers at the Kennedy Institute, University of Oxford, led by ...

Because of the increased risk of complications and potential for recurrence associated with invasive surgical techniques, there has been renewed interest in simple fasciotomy to treat flexion ...

Poor Neanderthals just couldn’t catch a break. Our ancient ancestors, who probably died out through inbreeding, passed along genes that are still present in modern-day humans. Research now finds that ...

A drug already on the market for 20 years effectively reduced nodules associated with Dupuytren's disease in a mid-stage trial, researchers said. Patients receiving intranodular injections of ...

Ventoux Biosciences, a San Diego–based company that aims to treat fibrotic diseases such as Dupuytren’s, has launched. Surgery is the current standard of care for Dupuytren’s disease, an inheritable ...

Researchers at the Kennedy Institute, University of Oxford, led by Professor Jagdeep Nanchahal have demonstrated the efficacy of the anti-TNF drug adalimumab for patients with early-stage Dupuytren's ...

Forget John Elway. Endo is looking to everyday patients to lead its refreshed Dupuytren’s contracture (DC) campaign. Endo tapped the former Denver Broncos quarterback to help lead its “Facts on Hand” ...

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Dupuytren's Disease Market - A Global and Regional Analysis: Focus on Drug Type and Region - Analysis and Forecast, 2025-2035" has been added to ...

The study also showed that if the contracture was corrected to 0˚ to 5˚ of flexion, recurrence rates were significantly lower and required no additional therapy. 12 In addition, most patients maintain ...